The US Food and Drug Administration (FDA) has approved Lembaz (adrabetadex) for the treatment of infantile-Niemann Pick disease type C (NPC). NPC is a complex lysosomal storage disorder mainly characterized by the accumulation of unesterified cholesterol in lysosomes....













How Sanofi is Addressing Supply Chain Issues
CheckRare November 17, 2026 1:48 pm